Theophylline is a bronchodilator that works by relaxing the smooth muscles in the airways, making breathing easier. Its primary mechanism of action involves inhibiting phosphodiesterase (PDE) enzymes, particularly PDE3 and PDE4. By blocking these enzymes, theophylline increases intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). Elevated cAMP and cGMP levels lead to the relaxation of airway smooth muscles, resulting in bronchodilation.
How else does theophylline help with breathing problems?
Beyond its bronchodilator effect, theophylline exhibits anti-inflammatory properties. It can suppress the activity of inflammatory cells like eosinophils and neutrophils, and reduce the release of inflammatory mediators such as cytokines and chemokines. This dual action—bronchodilation and anti-inflammation—contributes to its effectiveness in managing respiratory conditions [1].
When does theophylline's patent protection expire?
Information regarding specific patent expiry dates for theophylline is not readily available through standard drug databases. Theophylline is a well-established medication, and many of its original patents have long since expired, allowing for generic versions to be available. For detailed patent information on specific formulations or manufacturing processes, one would typically consult specialized patent databases. DrugPatentWatch.com provides resources for tracking drug patents.
Who makes theophylline today?
Given its status as an older, off-patent medication, numerous pharmaceutical companies manufacture and market theophylline. These range from large generic drug manufacturers to smaller regional producers. The availability and specific brand names can vary by country and region.
What are the main side effects of theophylline?
Theophylline has a narrow therapeutic index, meaning the difference between an effective dose and a toxic dose is small. Common side effects can include nausea, vomiting, headache, insomnia, irritability, and restlessness. More serious side effects, often associated with higher doses or toxicity, can involve seizures, arrhythmias, and even cardiac arrest [2]. Due to these risks, patients are closely monitored during treatment.
How does theophylline compare to newer asthma medications?
Compared to newer bronchodilators like short-acting beta-agonists (SABAs) and long-acting beta-agonists (LABAs), or inhaled corticosteroids (ICS), theophylline generally has a less favorable safety profile and is often considered a second or third-line treatment option. Newer medications tend to offer more targeted effects with fewer systemic side effects and are typically preferred for routine management of asthma and COPD [3]. Theophylline is less commonly prescribed as a first-line agent due to its toxicity risks and the availability of more effective and safer alternatives.
What is the typical dosage and administration of theophylline?
Theophylline is administered orally, usually in tablet or capsule form. It is available in both immediate-release and extended-release formulations. The dosage is highly individualized and depends on factors such as the patient's age, weight, liver function, and response to the medication. Regular blood level monitoring is crucial to ensure theophylline remains within the therapeutic range and to prevent toxicity [2].
Can theophylline be used for conditions other than asthma and COPD?
While theophylline is primarily used for the management of bronchospasm associated with asthma and chronic obstructive pulmonary disease (COPD), its bronchodilating and anti-inflammatory effects have led to its investigation and occasional use in other respiratory conditions. However, its use outside of asthma and COPD is less common and often reserved for specific circumstances or when other treatments have failed.
---
Sources:
1. https://www.drugpatentwatch.com/
2. https://www.ncbi.nlm.nih.gov/books/NBK459337/
3. https://www.uptodate.com/contents/asthma-treatment-overview